InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
21
T+90 hit rate
0%
T+90 mean return
-16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Touchon Pascal, Chairman & CEO. Insider active across 2 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 24 disclosures have been logged. Split: 0 buy · 21 sells. Total volume traded: €1.6m. History available since 18 May 2021. The latest transaction was disclosed on 16 August 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations24 total
276 shares@ US$6.630.1% of flowCommon StockSEC:0000905148-24-002306:1
2,762 shares@ US$6.6291.4% of flowCommon StockSEC:0000905148-24-002306:0
81,506 shares@ US$0.6174.0% of flowCommon StockSEC:0000905148-24-001561:0
24,844 shares@ US$0.721.4% of flowCommon StockSEC:0000905148-24-000911:0
1,280,000 shares0Common StockSEC:0000905148-24-000115:0
20,409 shares@ US$0.3890.6% of flowCommon StockSEC:0000905148-23-001513:0
21,432 shares@ US$1.6522.8% of flowCommon StockSEC:0001140361-23-040562:0
14,291 shares@ US$1.661.9% of flowCommon StockSEC:0001140361-23-032216:0
29,766 shares@ US$2.0374.8% of flowCommon StockSEC:0001140361-23-025559:0
15,679 shares@ US$3.6274.6% of flowCommon StockSEC:0001567619-23-004540:0
324,711 shares0Common StockSEC:0001140361-23-010102:0
15,591 shares@ US$4.495.8% of flowCommon StockSEC:0001140361-22-042380:0
14,806 shares@ US$5.0356.3% of flowCommon StockSEC:0001140361-22-030302:0
14,220 shares@ US$7.200.12% mcap12.5% of flowCommon StockSEC:0001567619-22-013481:0
13,913 shares@ US$5.3160.086% mcap9.1% of flowCommon StockSEC:0001140361-22-019978:0
180,565 shares0Common StockSEC:0001140361-22-007764:0
8,402 shares@ US$17.116931.0% of flowCommon StockSEC:0001567619-21-020781
8,402 shares@ US$17.11690.16% mcap16.4% of flowCommon StockSEC:0001567619-21-020781:0
8,223 shares@ US$12.5320.11% mcap11.4% of flowCommon StockSEC:0001567619-21-016151:0
8,223 shares@ US$12.53221.5% of flowCommon StockSEC:0001567619-21-016151
14,194 shares@ US$16.3210.24% mcap25.1% of flowCommon StockSEC:0001567619-21-012695:0
14,194 shares@ US$16.32147.5% of flowCommon StockSEC:0001567619-21-012695
8,313 shares@ US$14.5512.8% of flowCommon StockSEC:0001209191-21-034425
8,313 shares@ US$14.550.12% mcap12.8% of flowCommon StockSEC:0001209191-21-034425:0
24 of 24 declarations
About Touchon Pascal
Pascal Touchon is the President and CEO of Atara Biotherapeutics, Inc. He leads the company by implementing strategies aimed at improving performance and strengthening its market position.
